Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Colorcon
Harvard Business School
Dow
McKesson

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TRUVADA

See Plans and Pricing

« Back to Dashboard

505(b)(2) Clinical Trials for Truvada

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
New Combination NCT00641641 The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection Completed Merck Sharp & Dohme Corp. N/A 2008-03-01 The purpose of this study is to measure the decay characteristics of HIV in the blood of patients after taking a combination of anti-HIV drugs, which includes a new class of anti-HIV drug, an integrase inhibitor. This study explores how this new combination of therapy reduces virus in various compartments of the body and immune system.
New Combination NCT00641641 The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection Completed Kirby Institute N/A 2008-03-01 The purpose of this study is to measure the decay characteristics of HIV in the blood of patients after taking a combination of anti-HIV drugs, which includes a new class of anti-HIV drug, an integrase inhibitor. This study explores how this new combination of therapy reduces virus in various compartments of the body and immune system.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for Truvada

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00074581 Preventing Sexual Transmission of HIV With Anti-HIV Drugs Completed HIV Prevention Trials Network Phase 3 2005-02-01 This study will determine whether anti-HIV drugs can prevent the sexual transmission of HIV among couples in which one partner is HIV infected and the other is not.
NCT00074581 Preventing Sexual Transmission of HIV With Anti-HIV Drugs Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 3 2005-02-01 This study will determine whether anti-HIV drugs can prevent the sexual transmission of HIV among couples in which one partner is HIV infected and the other is not.
NCT00090779 Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV Terminated Adult AIDS Clinical Trials Group Phase 2 2005-01-01 Although some doctors favor starting anti-HIV treatment as soon as possible after patients learn they are infected, it is not known if treatment for recently infected patients results in long-term benefits or harm. The purpose of this study is to learn whether or not people should take anti-HIV drugs when they are first infected.
NCT00090779 Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV Terminated National Institute of Allergy and Infectious Diseases (NIAID) Phase 2 2005-01-01 Although some doctors favor starting anti-HIV treatment as soon as possible after patients learn they are infected, it is not known if treatment for recently infected patients results in long-term benefits or harm. The purpose of this study is to learn whether or not people should take anti-HIV drugs when they are first infected.
NCT00090779 Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV Terminated AIDS Clinical Trials Group Phase 2 2005-01-01 Although some doctors favor starting anti-HIV treatment as soon as possible after patients learn they are infected, it is not known if treatment for recently infected patients results in long-term benefits or harm. The purpose of this study is to learn whether or not people should take anti-HIV drugs when they are first infected.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Truvada

Condition Name

Condition Name for Truvada
Intervention Trials
HIV Infections 76
HIV 48
HIV Infection 18
HIV-1 Infection 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Truvada
Intervention Trials
HIV Infections 111
Acquired Immunodeficiency Syndrome 39
Infection 27
Communicable Diseases 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Truvada

Trials by Country

Trials by Country for Truvada
Location Trials
United States 510
Canada 54
South Africa 42
United Kingdom 39
France 35
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Truvada
Location Trials
California 47
Florida 33
North Carolina 32
Texas 31
Massachusetts 30
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Truvada

Clinical Trial Phase

Clinical Trial Phase for Truvada
Clinical Trial Phase Trials
Phase 4 70
Phase 3 45
Phase 2/Phase 3 5
[disabled in preview] 31
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Truvada
Clinical Trial Phase Trials
Completed 117
Recruiting 26
Not yet recruiting 17
[disabled in preview] 26
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Truvada

Sponsor Name

Sponsor Name for Truvada
Sponsor Trials
Gilead Sciences 54
Merck Sharp & Dohme Corp. 32
National Institute of Allergy and Infectious Diseases (NIAID) 23
[disabled in preview] 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Truvada
Sponsor Trials
Other 248
Industry 137
NIH 35
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Harvard Business School
Colorcon
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.